Positive Airway Pressure Devices Global Market Report 2024

Positive airway pressure devices are instruments designed to deliver pressurized air into the lungs, primarily utilized for treating obstructive sleep apnea (OSA).

The primary categories of positive airway pressure devices consist of continuous positive airway pressure (CPAP), auto-titrating positive airway pressure (APAP), and bilevel positive airway pressure (BiPAP). CPAP devices employ gentle air pressure to prevent airway obstruction and are applied in the treatment of individuals facing respiratory challenges during sleep. Auto-titrating positive airway pressure devices ascertain the optimal fixed level of CPAP for extended treatment, aiding in maintaining minimal pressure necessary to sustain airway integrity. BiPAP devices facilitate the passage of air through the lungs using two distinct machines - one for higher pressure during inhalation and another for lower pressure during exhalation. These devices find application in addressing sleep apnea, chronic obstructive pulmonary disease (COPD), and other related conditions. Users of positive airway pressure devices encompass hospitals and sleep labs, home care settings, and various healthcare facilities. These devices play a vital role in managing sleep-related breathing disorders and enhancing overall respiratory function.

The positive airway pressure devices market research report is one of a series of new reports that provides positive airway pressure devices market statistics, including positive airway pressure devices industry global market size, regional shares, competitors with a positive airway pressure devices market share, detailed positive airway pressure devices market segments, market trends and opportunities, and any further data you may need to thrive in the positive airway pressure devices industry. This positive airway pressure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The positive airway pressure devices market size has grown rapidly in recent years. It will grow from $3.94 billion in 2023 to $4.37 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The historical period's growth can be ascribed to the increasing demand for sleep apnea and respiratory therapy, the expansion of the aging population and prevalence of chronic diseases, the rise in home healthcare solutions, the application of positive airway pressure devices in neonatal and pediatric care, and the establishment of regulatory standards for medical devices.

The positive airway pressure devices market size is expected to see rapid growth in the next few years. It will grow to $6.72 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The anticipated growth in the forecast period can be attributed to the development of personalized and patient-centric airway pressure devices, the expansion of telemedicine and remote monitoring practices, the customization of devices tailored to specific respiratory conditions, the overall growth of telehealth and the establishment of virtual sleep clinics, and the increased utilization of positive airway pressure devices in sports and performance sleep applications. Prominent trends expected in the forecast period encompass the integration of artificial intelligence (AI) and machine learning in sleep disorder management, a focus on regulatory compliance to ensure the safety of airway pressure devices, the emergence of portable and travel-friendly Positive Airway Pressure (PAP) solutions, the development of pediatric and infant-specific PAP devices, and the advent of wearable PAP technology for continuous monitoring.

The positive airway pressure (PAP) devices market is anticipated to experience growth, driven by the increasing geriatric population. The elderly demographic is more susceptible to sleep apnea diseases, with a higher prevalence of obstructive sleep apnea (OSA) linked to age-related reductions in the size of the upper airway lumen. In the UK, it is projected that by 2043, seniors will constitute 24% of the total population, amounting to 17.4 million people. This demographic shift towards an older population is expected to contribute to the market's expansion due to the higher incidence of apnea in the elderly.

The growth of the positive airway pressure devices market is further fueled by the increasing prevalence of obstructive sleep apnea. This sleep disorder, characterized by repetitive breathing interruptions during sleep, is effectively treated with Positive Airway Pressure (PAP) devices. These devices provide a continuous or variable stream of pressurized air, preventing or reducing the airway obstructions typical of OSA. In the UK alone, there are up to 3.9 million individuals with moderate to severe obstructive sleep apnea (OSA). The surge in cases of obstructive sleep apnea is a significant driver for the positive airway pressure devices market.

Leading companies in the positive airway pressure devices market are focusing on innovation to enhance profitability. Notable among these innovations is the AirSense 11 PAP Series introduced by ResMed Inc. in August 2021. This line of PAP devices is designed to treat sleep apnea and features integrated humidifiers, AutoRamp technology, and an intuitive touchscreen for easier therapy setup and nightly usage. The series includes three distinct models - AutoSet, CPAP, and Elite - providing flexibility in therapy according to individual needs.

A notable trend in the positive airway pressure devices market is the rise of portable devices. Companies are investing in portable and user-friendly continuous positive airway pressure (CPAP) devices to offer effective and convenient breathing support. Transcend Inc., a US-based portable CPAP technology specialist, launched Transcend Micro in September 2022. This portable CPAP device is the smallest and lightest in its category, weighing less than a pound and measuring less than four inches. The focus on portability aims to facilitate sleep apnea therapy for individuals at home or during travel.

In March 2022, Owens & Minor, Inc., a US-based healthcare solutions company, completed the acquisition of Apria, Inc. for $1.6 billion. This strategic move enhances the comprehensive selection of ancillary goods available to serve individuals with both chronic and non-chronic ailments, establishing an extensive paradigm for product supply and distribution. Apria, Inc., the acquired company, is a US-based provider of integrated home healthcare equipment and services, including continuous positive airway pressure (CPAP).

Major companies operating in the positive airway pressure devices market include ResMed Corporation, Royal Philips N.V., 3B Medical Corporation, Fisher & Paykel Healthcare Corporation Limited, Drive DeVilbiss Healthcare Inc., Somnetics International Corporation, Heyer-Schulte Medical Corp., Genstar Technologies LLC, BMC Medical Inc., Apex Medical Corporation, Armstrong Medical Industries Inc., Curative Medical Corporation, Compumedics Corporation Limited, CareFusion Corporation, Mercury Medical Inc., Khayat Medical Industries S.A.R.L, Vyaire Medical Inc., Teijin Limited, Medtronic PLC, Servona AG, Medical Depot Corporation, Weinmann Emergency Medical Technology GmbH & Co. KG, Beijing Dehaier Medical Technology Co. Ltd., Breas Medical AB, Cadwell Industries Corporation, General Electric Healthcare, Hamilton Medical AG, Invacare Corporation, Medline Industries Inc., Nihon Kohden Corporation, Oventus Medical Limited, SomnoMed Limited

North America was the largest region in the positive airway pressure devices market in 2023. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the positive airway pressure devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the positive airway pressure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The positive airway pressure devices market consists of sales of adjustable positive airway pressure and variable positive airway pressure devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.